Literature DB >> 3260936

Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction.

G Pantaleo1, M R Zocchi, S Ferrini, A Poggi, G Tambussi, C Bottino, L Moretta, A Moretta.   

Abstract

We have analyzed the transmembrane signaling operating in human cytolytic lymphocytes lacking surface expression of the CD3/TCR complex. Peripheral blood lymphocytes were fractionated into CD3+ and CD3- on the FACS and cloned under limiting conditions in the presence of PHA and IL-2. Approximately 90% CD3+ and 10% CD3- cells underwent clonal expansion. Clones obtained from the CD3- fraction belonged to two main phenotypic groups: CD2+ CD7+ and CD2- CD7+. Several clones were expanded and analyzed for surface phenotype and function. All of the five clones selected for detailed analysis did not express CD4, CD8, and CD28 antigens and did not release IL-2, whereas they displayed cytolytic activity against NK-sensitive, NK-resistant, and fresh tumor target cells. After stimulation with anti-CD2 mAbs or PHA a rapid increase in [Ca2+]i was detected in CD3- CD2+ CD7+ clones. This increment was caused by the release of Ca2+ from intracellular stores and by the influx from the extracellular compartment. Signaling in response to PHA did not appear to be dependent upon surface expression of CD2 molecules since antibody-induced modulation of CD2 did not prevent PHA-induced signal transduction. Similarly, in CD3- CD2- CD7+ clones [Ca2+]i increments and inositol phosphate formation occurred after stimulation with PHA. These data indicate that the functional PHA-binding structures, expressed in both groups of CD3- clones, are distinct from CD3/TCR complex and CD2 molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260936      PMCID: PMC2188963          DOI: 10.1084/jem.168.1.13

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  CD3+ WT31- peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer.

Authors:  A Poggi; C Bottino; M R Zocchi; G Pantaleo; E Ciccone; C Mingari; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

2.  Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

Authors:  A Moretta; A Poggi; D Olive; C Bottino; C Fortis; G Pantaleo; L Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

4.  Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium.

Authors:  A Weiss; J Imboden; D Shoback; J Stobo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.

Authors:  A Mantovani; P Allavena; C Sessa; G Bolis; C Mangioni
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

6.  Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates.

Authors:  G Pantaleo; D Olive; A Poggi; W J Kozumbo; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

7.  Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation.

Authors:  G Pantaleo; D Olive; A Poggi; T Pozzan; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

8.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

Authors:  S C Meuer; J C Hodgdon; R E Hussey; J P Protentis; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

9.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

Authors:  S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.

Authors:  A Moretta; G Pantaleo; L Moretta; M C Mingari; J C Cerottini
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The molecular basis of natural killer (NK) cell recognition and function.

Authors:  L Moretta; M C Mingari; D Pende; C Bottino; R Biassoni; A Moretta
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

2.  Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.

Authors:  E F Spour; T Leemhuis; L Jenski; R Redmond; D Fillak; J Jansen
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

Authors:  P T Schellekens; M T Roos; F De Wolf; J M Lange; F Miedema
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.

Authors:  G C Starling; D N Hart
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system.

Authors:  V Groh; S Porcelli; M Fabbi; L L Lanier; L J Picker; T Anderson; R A Warnke; A K Bhan; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

6.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

Authors:  A Moretta; C Bottino; D Pende; G Tripodi; G Tambussi; O Viale; A Orengo; M Barbaresi; A Merli; E Ciccone
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

7.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

Review 8.  A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies.

Authors:  Veronica Ramos-Mejia; Jose Arellano-Galindo; Juan Manuel Mejía-Arangure; Mario Ernesto Cruz-Munoz
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.